Erdafitinib is designed to treat metastatic urothelial carcinoma, specifically when there are FGFR2/3 changes. It stops the FGFR signaling in its tracks. You’ve got three strength options: 3, 4, and 5 mg of the stuff, all with a film coating.
The suggested dosage is 8 mg daily, but it could be bumped up to 9 mg if needed. Each bottle comes with 56 tablets.
